These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24437006)

  • 1. [Management of oral anticoagulants by elderly patients at home].
    Pautas E; Naline C; Golmard JL; Montni A
    Soins Gerontol; 2013; (104):11-5. PubMed ID: 24437006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the impact of a training program on vitamin K antagonists (VKA) implemented by pharmacy students aiming at improving the knowledge of patients receiving vitamin K antagonists during their hospital clinical training course].
    Conort O; Siguret V; Bourdon O; Nazaraly S; Brignone M; Pons-Kerjean N; Houze S; Laribe Cage S; Berthet F; Golmard JL; Brion F; Tilleul P
    Ann Pharm Fr; 2014 Jul; 72(4):287-95. PubMed ID: 24997889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy education for patients receiving oral anti-coagulants vitamin K antagonists].
    Satger B; Blaise S; Fontaine M; Yver J; Allenet B; Baudrant M; Pernod G; Bosson JL
    Presse Med; 2009 Dec; 38(12):1780-7. PubMed ID: 19815369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic education of elderly patients under antivitamin - K treatment: evaluation of the program after 5 years].
    Thiriat N; Peyron I; Bernard-Charrière S; Monti A; Pariel S; Pautas E
    J Pharm Belg; 2014 Sep; (3):30-7. PubMed ID: 25226761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K antagonists in patients with nonvalvular atrial fibrillation: appropriateness and quality of treatment in an Italian cohort.
    Pereira de Sousa L; Burba I; Ruperto C; Lattuada L; Barbone F; Di Chiara A
    J Cardiovasc Med (Hagerstown); 2013 Jul; 14(7):534-40. PubMed ID: 23328227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When the rubber meets the road: adherence and persistence with non-vitamin K antagonist oral anticoagulants and old oral anticoagulants in the real world-a problem or a myth ?
    Suryanarayan D; Schulman S
    Semin Thromb Hemost; 2014 Nov; 40(8):852-9. PubMed ID: 25384183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the knowledge of patients about the management of treatment with anti-vitamin K drugs in the Service of Cardiology of Ouagadougou].
    Samadoulougou AK; Naibe DT; Mandi DG; Kabore E; Millogo GR; Yameogo NV; Kologo JK; Tall AT; Toguyeni BJ; Zabsonre P
    Ann Cardiol Angeiol (Paris); 2015 Sep; 64(4):263-7. PubMed ID: 26275496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulant treatment - evaluating the knowledge of patients admitted in physical medicine and rehabilitation units.
    Janoly-Duménil A; Bourne C; Loiseau K; Luauté J; Sancho PO; Ciancia S; Caillet F; Boisson D; Rioufol C; Plauchu MM; Rode G; Jacquin-Courtois S
    Ann Phys Rehabil Med; 2011 May; 54(3):172-80. PubMed ID: 21474406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk and management of anti-vitamin K in the elderly].
    Pautas E
    Rev Prat; 2009 Dec; 59(10):1377-81. PubMed ID: 20058757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of vitamin K antagonist overcoagulation.
    Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
    QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial.
    Mahaffey KW; Wojdyla D; Hankey GJ; White HD; Nessel CC; Piccini JP; Patel MR; Berkowitz SD; Becker RC; Halperin JL; Singer DE; Califf RM; Fox KA; Breithardt G; Hacke W
    Ann Intern Med; 2013 Jun; 158(12):861-8. PubMed ID: 23778903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation.
    Poli D; Antonucci E; Testa S; Tosetto A; Ageno W; Palareti G;
    Circulation; 2011 Aug; 124(7):824-9. PubMed ID: 21810658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision making for oral anticoagulants in atrial fibrillation: the ATA-AF study.
    Gussoni G; Di Pasquale G; Vescovo G; Gulizia M; Mathieu G; Scherillo M; Panuccio D; Lucci D; Nozzoli C; Fabbri G; Colombo F; Riva L; Baldo CI; Maggioni AP; Mazzone A;
    Eur J Intern Med; 2013 Jun; 24(4):324-32. PubMed ID: 23684591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [When to replace the vitamin K antagonists by new anticoagulants?].
    Fournet M; Daubert JC
    Rev Prat; 2013 Sep; 63(7):970-5. PubMed ID: 24167900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-dose drug dispensing as a tool to improve medication adherence: A study in patients using vitamin K antagonists.
    van Rein N; de Geus KS; Cannegieter SC; Reitsma PH; van der Meer FJM; Lijfering WM
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):46-51. PubMed ID: 29108127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Educational and information needs of patients under vitamin K antagonist therapy].
    Ben Jeddou K; Ben M'Barka F; Boukhris I; Arfaoui H; Baccar H; Khalfalah N; Ouhachi Z
    Rev Med Interne; 2018 Jul; 39(7):546-550. PubMed ID: 29789192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of vitamin K antagonist overcoagulation. A case-control study in unselected patients referred to an emergency department.
    Cadiou G; Varin R; Levesque H; Grassi V; Benichou J; Tiret I; Dieu B; Lecam-Duchez V; Borg JY; Muller JM; Benhamou Y; Marie I
    Thromb Haemost; 2008 Oct; 100(4):685-92. PubMed ID: 18841293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and wishes of patients as regards vitamin K antagonists: a cross-sectional survey in Western Brittany, France.
    Cornec B; Nabbe N; Oger E
    Therapie; 2011; 66(4):363-8. PubMed ID: 21851801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of dietary vitamin K in the management of oral vitamin K antagonists.
    Holmes MV; Hunt BJ; Shearer MJ
    Blood Rev; 2012 Jan; 26(1):1-14. PubMed ID: 21914559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A long-term follow-up quality evaluation of patients taking oral anticoagulant therapy].
    Chastagner M; Gault M; Aboyans V; Lacroix P
    Arch Mal Coeur Vaiss; 2005 Mar; 98(3):199-204. PubMed ID: 15816322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.